Do analysts recommend ONMD or LUCY?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OneMedNet 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Innovative Eyewear 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Does the media prefer ONMD or LUCY?

In the previous week, Innovative Eyewear had 1 more articles in the media than OneMedNet. MarketBeat recorded 3 mentions for Innovative Eyewear and 2 mentions for OneMedNet. OneMedNet's average media sentiment score of 0.94 beat Innovative Eyewear's score of 0.30 indicating that OneMedNet is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OneMedNet 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Innovative Eyewear 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend OPRX or ONMD?

OptimizeRx presently has a consensus price target of $11.43, indicating a potential upside of 47.37%. Given OptimizeRx's stronger consensus rating and higher possible upside, research analysts plainly believe OptimizeRx is more favorable than OneMedNet. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OptimizeRx 1 Sell rating(s) 2 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.56 OneMedNet 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings and valuation, OPRX or ONMD?

OptimizeRx has higher revenue and earnings than OneMedNet. OneMedNet is trading at a lower price-to-earnings ratio than OptimizeRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio OptimizeRx $109.43M 1.34 $5.13M $0.23 33.72 OneMedNet $1.36M 28.60 -$2.80M -$0.16 N/A

Is OPRX or ONMD more profitable?

OptimizeRx has a net margin of 4.66% compared to OneMedNet's net margin of -584.20%. OptimizeRx's return on equity of 9.44% beat OneMedNet's return on equity. Company Net Margins Return on Equity Return on Assets OptimizeRx 4.66% 9.44% 7.11% OneMedNet -584.20% N/A -521.20%

Does the media refer more to OPRX or ONMD?

In the previous week, OptimizeRx had 1 more articles in the media than OneMedNet. MarketBeat recorded 3 mentions for OptimizeRx and 2 mentions for OneMedNet. OneMedNet's average media sentiment score of 0.94 beat OptimizeRx's score of 0.93 indicating that OneMedNet is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OptimizeRx 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive OneMedNet 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend HCAT or ONMD?

Health Catalyst presently has a consensus target price of $2.45, indicating a potential upside of 40.40%. Given Health Catalyst's stronger consensus rating and higher possible upside, equities research analysts clearly believe Health Catalyst is more favorable than OneMedNet. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Health Catalyst 1 Sell rating(s) 7 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.18 OneMedNet 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media favor HCAT or ONMD?

In the previous week, Health Catalyst and Health Catalyst both had 2 articles in the media. OneMedNet's average media sentiment score of 0.94 beat Health Catalyst's score of 0.91 indicating that OneMedNet is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Health Catalyst 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive OneMedNet 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate DH or ONMD?

Definitive Healthcare currently has a consensus target price of $1.47, indicating a potential upside of 42.17%. Given Definitive Healthcare's stronger consensus rating and higher probable upside, equities analysts clearly believe Definitive Healthcare is more favorable than OneMedNet. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Definitive Healthcare 3 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 1.90 OneMedNet 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media refer more to DH or ONMD?

In the previous week, Definitive Healthcare had 1 more articles in the media than OneMedNet. MarketBeat recorded 3 mentions for Definitive Healthcare and 2 mentions for OneMedNet. OneMedNet's average media sentiment score of 0.94 beat Definitive Healthcare's score of 0.82 indicating that OneMedNet is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Definitive Healthcare 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive OneMedNet 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate CCLD or ONMD?

CareCloud currently has a consensus target price of $3.25, suggesting a potential upside of 53.66%. Given CareCloud's stronger consensus rating and higher possible upside, analysts clearly believe CareCloud is more favorable than OneMedNet. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CareCloud 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33 OneMedNet 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation and earnings, CCLD or ONMD?

CareCloud has higher revenue and earnings than OneMedNet. OneMedNet is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CareCloud $120.50M 0.75 $10.80M $0.07 30.21 OneMedNet $1.36M 28.60 -$2.80M -$0.16 N/A

Is CCLD or ONMD more profitable?

CareCloud has a net margin of 6.21% compared to OneMedNet's net margin of -584.20%. CareCloud's return on equity of 27.07% beat OneMedNet's return on equity. Company Net Margins Return on Equity Return on Assets CareCloud 6.21% 27.07% 14.56% OneMedNet -584.20% N/A -521.20%

OneMedNet (ONMD) Competitors

$0.66 +0.00 (+0.52%)

As of 12:30 PM Eastern

Compare

ONMD vs. LUCY, OPRX, HCAT, DH, and CCLD

Should you buy OneMedNet stock or one of its competitors? OneMedNet's main competitors and comparable companies include Innovative Eyewear (LUCY), OptimizeRx (OPRX), Health Catalyst (HCAT), Definitive Healthcare (DH), and CareCloud (CCLD). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare" sector.

How does OneMedNet compare to Innovative Eyewear?

OneMedNet (NASDAQ:ONMD) and Innovative Eyewear (NASDAQ:LUCY) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, risk, media sentiment, profitability, valuation, dividends and earnings.

OneMedNet has higher earnings, but lower revenue than Innovative Eyewear. OneMedNet is trading at a lower price-to-earnings ratio than Innovative Eyewear, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OneMedNet	$1.36M	28.60	-$2.80M	-$0.16	N/A
Innovative Eyewear	$2.66M	2.72	-$7.59M	-$1.29	N/A

OneMedNet has a beta of 1.12, suggesting that its stock price is 12% more volatile than the broader market. Comparatively, Innovative Eyewear has a beta of 2.76, suggesting that its stock price is 176% more volatile than the broader market.

1.0% of OneMedNet shares are owned by institutional investors. Comparatively, 1.0% of Innovative Eyewear shares are owned by institutional investors. 50.2% of OneMedNet shares are owned by insiders. Comparatively, 1.7% of Innovative Eyewear shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Innovative Eyewear had 1 more articles in the media than OneMedNet. MarketBeat recorded 3 mentions for Innovative Eyewear and 2 mentions for OneMedNet. OneMedNet's average media sentiment score of 0.94 beat Innovative Eyewear's score of 0.30 indicating that OneMedNet is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OneMedNet	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Innovative Eyewear	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Innovative Eyewear has a net margin of -225.26% compared to OneMedNet's net margin of -584.20%. OneMedNet's return on equity of 0.00% beat Innovative Eyewear's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OneMedNet	-584.20%	N/A	-521.20%
Innovative Eyewear	-225.26%	-88.90%	-80.34%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OneMedNet	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Innovative Eyewear	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Summary

Innovative Eyewear beats OneMedNet on 8 of the 14 factors compared between the two stocks.

How does OneMedNet compare to OptimizeRx?

OptimizeRx (NASDAQ:OPRX) and OneMedNet (NASDAQ:ONMD) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, media sentiment, institutional ownership, valuation, risk, analyst recommendations and earnings.

OptimizeRx has a beta of 1.09, indicating that its stock price is 9% more volatile than the broader market. Comparatively, OneMedNet has a beta of 1.12, indicating that its stock price is 12% more volatile than the broader market.

76.5% of OptimizeRx shares are held by institutional investors. Comparatively, 1.0% of OneMedNet shares are held by institutional investors. 7.5% of OptimizeRx shares are held by company insiders. Comparatively, 50.2% of OneMedNet shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

OptimizeRx has higher revenue and earnings than OneMedNet. OneMedNet is trading at a lower price-to-earnings ratio than OptimizeRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OptimizeRx	$109.43M	1.34	$5.13M	$0.23	33.72
OneMedNet	$1.36M	28.60	-$2.80M	-$0.16	N/A

OptimizeRx presently has a consensus price target of $11.43, indicating a potential upside of 47.37%. Given OptimizeRx's stronger consensus rating and higher possible upside, research analysts plainly believe OptimizeRx is more favorable than OneMedNet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OptimizeRx	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56
OneMedNet	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, OptimizeRx had 1 more articles in the media than OneMedNet. MarketBeat recorded 3 mentions for OptimizeRx and 2 mentions for OneMedNet. OneMedNet's average media sentiment score of 0.94 beat OptimizeRx's score of 0.93 indicating that OneMedNet is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OptimizeRx	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
OneMedNet	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

OptimizeRx has a net margin of 4.66% compared to OneMedNet's net margin of -584.20%. OptimizeRx's return on equity of 9.44% beat OneMedNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OptimizeRx	4.66%	9.44%	7.11%
OneMedNet	-584.20%	N/A	-521.20%

Summary

OptimizeRx beats OneMedNet on 12 of the 16 factors compared between the two stocks.

How does OneMedNet compare to Health Catalyst?

Health Catalyst (NASDAQ:HCAT) and OneMedNet (NASDAQ:ONMD) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, analyst recommendations, institutional ownership, dividends, profitability, earnings and risk.

Health Catalyst has a beta of 1.53, suggesting that its stock price is 53% more volatile than the broader market. Comparatively, OneMedNet has a beta of 1.12, suggesting that its stock price is 12% more volatile than the broader market.

Health Catalyst presently has a consensus target price of $2.45, indicating a potential upside of 40.40%. Given Health Catalyst's stronger consensus rating and higher possible upside, equities research analysts clearly believe Health Catalyst is more favorable than OneMedNet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health Catalyst	1 Sell rating(s)	7 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.18
OneMedNet	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

85.0% of Health Catalyst shares are held by institutional investors. Comparatively, 1.0% of OneMedNet shares are held by institutional investors. 19.4% of Health Catalyst shares are held by company insiders. Comparatively, 50.2% of OneMedNet shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Health Catalyst and Health Catalyst both had 2 articles in the media. OneMedNet's average media sentiment score of 0.94 beat Health Catalyst's score of 0.91 indicating that OneMedNet is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Health Catalyst	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
OneMedNet	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

OneMedNet has lower revenue, but higher earnings than Health Catalyst. OneMedNet is trading at a lower price-to-earnings ratio than Health Catalyst, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Health Catalyst	$311.14M	0.42	-$177.97M	-$3.68	N/A
OneMedNet	$1.36M	28.60	-$2.80M	-$0.16	N/A

Health Catalyst has a net margin of -90.61% compared to OneMedNet's net margin of -584.20%. OneMedNet's return on equity of 0.00% beat Health Catalyst's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Health Catalyst	-90.61%	-1.83%	-0.80%
OneMedNet	-584.20%	N/A	-521.20%

Summary

Health Catalyst beats OneMedNet on 9 of the 15 factors compared between the two stocks.

How does OneMedNet compare to Definitive Healthcare?

Definitive Healthcare (NASDAQ:DH) and OneMedNet (NASDAQ:ONMD) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their risk, profitability, earnings, dividends, institutional ownership, media sentiment, analyst recommendations and valuation.

98.7% of Definitive Healthcare shares are owned by institutional investors. Comparatively, 1.0% of OneMedNet shares are owned by institutional investors. 17.1% of Definitive Healthcare shares are owned by insiders. Comparatively, 50.2% of OneMedNet shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

OneMedNet has lower revenue, but higher earnings than Definitive Healthcare. OneMedNet is trading at a lower price-to-earnings ratio than Definitive Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Definitive Healthcare	$241.52M	0.46	-$138.93M	-$1.60	N/A
OneMedNet	$1.36M	28.60	-$2.80M	-$0.16	N/A

Definitive Healthcare currently has a consensus target price of $1.47, indicating a potential upside of 42.17%. Given Definitive Healthcare's stronger consensus rating and higher probable upside, equities analysts clearly believe Definitive Healthcare is more favorable than OneMedNet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Definitive Healthcare	3 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	1.90
OneMedNet	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Definitive Healthcare had 1 more articles in the media than OneMedNet. MarketBeat recorded 3 mentions for Definitive Healthcare and 2 mentions for OneMedNet. OneMedNet's average media sentiment score of 0.94 beat Definitive Healthcare's score of 0.82 indicating that OneMedNet is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Definitive Healthcare	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
OneMedNet	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Definitive Healthcare has a beta of 1.4, suggesting that its stock price is 40% more volatile than the broader market. Comparatively, OneMedNet has a beta of 1.12, suggesting that its stock price is 12% more volatile than the broader market.

Definitive Healthcare has a net margin of -72.28% compared to OneMedNet's net margin of -584.20%. Definitive Healthcare's return on equity of 3.55% beat OneMedNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Definitive Healthcare	-72.28%	3.55%	1.63%
OneMedNet	-584.20%	N/A	-521.20%

Summary

Definitive Healthcare beats OneMedNet on 11 of the 16 factors compared between the two stocks.

How does OneMedNet compare to CareCloud?

CareCloud (NASDAQ:CCLD) and OneMedNet (NASDAQ:ONMD) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, media sentiment, risk, analyst recommendations, earnings, institutional ownership, valuation and dividends.

CareCloud has a net margin of 6.21% compared to OneMedNet's net margin of -584.20%. CareCloud's return on equity of 27.07% beat OneMedNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CareCloud	6.21%	27.07%	14.56%
OneMedNet	-584.20%	N/A	-521.20%

CareCloud has higher revenue and earnings than OneMedNet. OneMedNet is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CareCloud	$120.50M	0.75	$10.80M	$0.07	30.21
OneMedNet	$1.36M	28.60	-$2.80M	-$0.16	N/A

CareCloud currently has a consensus target price of $3.25, suggesting a potential upside of 53.66%. Given CareCloud's stronger consensus rating and higher possible upside, analysts clearly believe CareCloud is more favorable than OneMedNet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CareCloud	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
OneMedNet	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

10.2% of CareCloud shares are held by institutional investors. Comparatively, 1.0% of OneMedNet shares are held by institutional investors. 14.8% of CareCloud shares are held by company insiders. Comparatively, 50.2% of OneMedNet shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, OneMedNet had 1 more articles in the media than CareCloud. MarketBeat recorded 2 mentions for OneMedNet and 1 mentions for CareCloud. CareCloud's average media sentiment score of 1.87 beat OneMedNet's score of 0.94 indicating that CareCloud is being referred to more favorably in the media.

Company	Overall Sentiment
CareCloud	Very Positive
OneMedNet	Positive

CareCloud has a beta of 1.5, indicating that its stock price is 50% more volatile than the broader market. Comparatively, OneMedNet has a beta of 1.12, indicating that its stock price is 12% more volatile than the broader market.

Summary

CareCloud beats OneMedNet on 13 of the 16 factors compared between the two stocks.

Get OneMedNet News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ONMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ONMD vs. The Competition

Export

Metric	OneMedNet	Healthcare Technology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$38.01M	$1.70B	$7.21B	$12.75B
Dividend Yield	N/A	4.70%	2.57%	11.71%
P/E Ratio	-4.01	20.75	274.47	25.48
Price / Sales	28.60	90.86	637.09	88.51
Price / Cash	N/A	31.57	28.42	34.96
Price / Book	-10.93	6.17	10.38	6.26
Net Income	-$2.80M	-$18.66M	$3.49B	$358.19M
7 Day Performance	-3.80%	-0.58%	-2.11%	-1.31%
1 Month Performance	-16.03%	2.03%	0.52%	-2.59%
1 Year Performance	-22.22%	-13.53%	24.69%	8.65%

OneMedNet Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ONMD OneMedNet	1.0755 of 5 stars	$0.66 +0.5%	N/A	-22.6%	$38.01M	$1.36M	N/A	2
LUCY Innovative Eyewear	0.6079 of 5 stars	$0.85 -2.6%	N/A	-56.2%	$7.27M	$3.41M	N/A	9	Short Interest Increase
OPRX OptimizeRx	3.81 of 5 stars	$7.28 -4.3%	$11.43 +57.1%	-57.9%	$137.06M	$109.43M	31.63	100	News Coverage
HCAT Health Catalyst	3.1898 of 5 stars	$1.74 +2.1%	$2.45 +41.2%	-45.7%	$132.08M	$311.14M	N/A	1,200	Gap Down
DH Definitive Healthcare	3.082 of 5 stars	$1.04 +1.5%	$1.47 +42.2%	-74.7%	$110.48M	$232.70M	N/A	970	Analyst Upgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ONMD) was last updated on 9/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

OneMedNet (ONMD) Competitors

ONMD vs. LUCY, OPRX, HCAT, DH, and CCLD

How does OneMedNet compare to Innovative Eyewear?

Summary

How does OneMedNet compare to OptimizeRx?

Summary

How does OneMedNet compare to Health Catalyst?

Summary

How does OneMedNet compare to Definitive Healthcare?

Summary

How does OneMedNet compare to CareCloud?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ONMD vs. The Competition

OneMedNet Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

OneMedNet (ONMD) Competitors

ONMD vs. LUCY, OPRX, HCAT, DH, and CCLD

How does OneMedNet compare to Innovative Eyewear?

Which has stronger valuation & earnings, ONMD or LUCY?

Which has more risk and volatility, ONMD or LUCY?

Do institutionals & insiders have more ownership in ONMD or LUCY?

Does the media prefer ONMD or LUCY?

Is ONMD or LUCY more profitable?

Do analysts recommend ONMD or LUCY?

Summary

How does OneMedNet compare to OptimizeRx?

Which has more risk & volatility, OPRX or ONMD?

Do institutionals and insiders believe in OPRX or ONMD?

Which has preferable earnings and valuation, OPRX or ONMD?

Do analysts recommend OPRX or ONMD?

Does the media refer more to OPRX or ONMD?

Is OPRX or ONMD more profitable?

Summary

How does OneMedNet compare to Health Catalyst?

Which has more risk and volatility, HCAT or ONMD?

Do analysts recommend HCAT or ONMD?

Do institutionals & insiders believe in HCAT or ONMD?

Does the media favor HCAT or ONMD?

Which has preferable earnings and valuation, HCAT or ONMD?

Is HCAT or ONMD more profitable?

Summary

How does OneMedNet compare to Definitive Healthcare?

Do institutionals and insiders believe in DH or ONMD?

Which has higher valuation and earnings, DH or ONMD?

Do analysts rate DH or ONMD?

Does the media refer more to DH or ONMD?

Which has more risk and volatility, DH or ONMD?

Is DH or ONMD more profitable?

Summary

How does OneMedNet compare to CareCloud?

Is CCLD or ONMD more profitable?

Which has better valuation and earnings, CCLD or ONMD?

Do analysts rate CCLD or ONMD?

Do institutionals & insiders hold more shares of CCLD or ONMD?

Does the media favor CCLD or ONMD?

Which has more risk & volatility, CCLD or ONMD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ONMD vs. The Competition

OneMedNet Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools